Erin McEvoy

Here, we bring you our top five recent articles covering safety regulations in North Carolina, licenses in Minnesota, the FDA’s FY2026 Agriculture appropriations bill, cannabis taxes in California, and antifungal properties of CBD and CBDV.

Researchers analyzed national data over a 16-year timeframe to identify who receives treatment for cannabis use disorder (CUD).

Several cease and desist letters were sent to companies in regard to hemp products containing THCA that potentially violate the Missouri Merchandising Practices Act.

With the privatization of its produce business complete, the company intends to focus on global cannabis operations.

The cannabinoids cannabidiol (CBD) and cannabidivarin (CBDV) showed antifungal activity in both in vivo tests and in vitro wound models.

Here, we bring you our top five recent articles covering unlicensed cannabis purchases in New Jersey, cannabis found in Haribo candy, regulating cannabis beverages in Kentucky, appeals court rejects argument against federal prohibition, and organic certification in the industry.

According to two House Bills, medical cannabis must now be sold in pre-packaged form, with new regulations and licenses for transportation, storage, and security of facilities.

The nationwide initiative Mission [Green] supports individuals impacted by cannabis prohibition, and advocates for social justice and equity.

In this interview clip from our Women in Grow: Leadership in Cannabis Genetics and Cultivation supplement, Anna Schwabe, PhD explains mislabeling and record-keeping in the industry.

The law outlines a new framework for the sale of beverages containing intoxicating cannabinoids.

The Court recently published its opinion upholding previous rulings, despite shifting legalization trends in the past two decades.

Here, we bring you our top five recent articles covering a survey on veterans and medical cannabis treatment, a new White Earth dispensary location, New Mexico’s basic income pilot program, social equity licenses in Washington State, and our new podcast episode.

In this month’s webinar, Dustin Sulak, DO, summarizes and provides insights on cannabis studies for chronic pain, restless leg syndrome, insomnia, effects on driving, and more.

Listen to a Noid Factoid from David Sandelman COO, CTO & Co-Founder of Cannatrol.

As Texas advances legislation to ban hemp-derived THC, HB 46 seeks to expand the state’s medical cannabis program, with several recent changes.

Nearly halfway through 2025, let’s revisit what new scientific updates and insights have been happening in the industry.

Here, we bring you our top five recent articles covering hemp restrictions in Alabama and Texas, data on medical cannabis patients and sleep apnea, FDA making psychedelics a top priority, and research on cannabis use and sperm quality.

Industry stakeholders responded to the bill, which would prohibit the sale and possession of hemp-derived THC, among other restrictions.

In this interview clip from our Women in Grow: Leadership in Cannabis Genetics and Cultivation supplement, Anna Schwabe, PhD explains her research on variations in cannabis genetics and their significance.

Researchers analyzed data from 262 counties, identifying sociodemographic characterizations, associations, and discrepancies.

The report includes data from enrolled patients on products purchased, benefits, and side effects.

The study also identified a new cannabinoid in the plant, named cannabielsoxa.

Here, we bring you our top five recent articles covering cannabis legalization bills in Pennsylvania and Virginia, hemp regulation compliance in California, the first map of tribal cannabis and hemp programs, and a study on cannabis consumption and a sedentary lifestyle.

The first-of-its-kind survey from ASTM International aims to build a cannabis and hemp standards roadmap for 2030.

The study examined data from nearly 20,000 individuals and found no link between cannabis users and non-users and levels of physical activity.

Recently introduced legislation in Maine focuses on testing and safety for medical cannabis in the state.

The survey asked about patient cannabis use, openness to discussing cannabis as part of treatment plans, and perspectives on substance use of physicians.

In this interview clip from our Women in Grow: Leadership in Cannabis Genetics and Cultivation supplement, Anna Schwabe, PhD shares her educational background in plant genetics.

The emergency regulations, effective in September 2024, prohibit hemp products in California to contain any THC.

Here, we bring you our top five recent articles covering a cannabis advertising ban in Mississippi, reforms urged in Canada, the latest Healer webinar, a study on THC and driving skills, and intoxicating hemp product sales in Ohio.